Scott M. Coiante - SVP, Chief Financial Officer at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Financial Officer
Issuer Symbol
APRE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Scott M. Coiante since 08 Feb 2025

Holdings reported by Scott M. Coiante for Aprea Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 145,065 $533,970 $3.68 28 Jul 2022 Direct
Stock Option (right to Buy) 89,200 28 Jul 2022 Direct Common Stock

Transactions reported by Scott M. Coiante for Aprea Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.